检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:李孝安[1] 高良敏[1] 陈良[1] 鲁建波[1] 李顺祥[1] 郭春园[1] 普学云[1] 刘小春[1] 蔡英[1]
机构地区:[1]云南省玉溪市疾病预防控制中心,云南玉溪653100
出 处:《中国皮肤性病学杂志》2010年第10期892-895,共4页The Chinese Journal of Dermatovenereology
基 金:云南省玉溪市卫生局科研基金资助项目(编号:2008-9038)
摘 要:目的了解完成联合化疗的麻风患者的疗效,并探讨寿命表法在麻风患者疗效评估方面的应用前景。方法采用历史队列研究的方法,收集玉溪市1986-2006年完成联合化疗的369例麻风患者的临床资料,结果用SPSS15.0统计软件进行统计学分析。结果 369例麻风患者中,男270例(占73.17%),女99例(占26.83%);农民334例(占90.51%),小学及以下文化程度者244例(占66.14%);联合化疗治疗后复发率为0,中位治愈时间为5.07(3.99,6.23)年,寿命表法计算结果显示,在接受治疗2~6年内累计治愈率为88.30%,确诊15年后累计的生存概率为84.62%。结论寿命表法在计算累计治愈率方面具有连续性和动态性特征,可用于麻风的疗效评估;麻风联合化疗治愈时间较短,累计生存概率较高,寿命表法在评估麻风病化疗疗效方面有良好的应用前景。Objective To understand the efficacy of leprosy after using multidrug therapy(MDT),and to explore the prospect of efficacy assessment among the leprosy using life-table method.Method Using historical cohort method,a total of 369 leprosy case information were collected from 1986 to 2006 in Yuxi City of Yunnan Province,and these data were analyzed by SPSS15.0.Result Among the 369 cases of leprosy,73.17% were males,and 90.51% of them were farmers,and 66.10% of them received primary school and below education,the MDT recurrence rate was 0,and the median of the cure time was 5.07(3.99,6.23)years in this study.Using Life-table method the accumulative cure rate was 88.30% these patients were received MDT from 2 to 6 years,and the accumulative survival rate was 84.62% these patients have been diagnosed leprosy 15 years in this study.Conclusion Life-table method is continuity and dynamic in calculating the accumulative cure rate and accumulative survival rate,it can be used to assess the efficacy of leprosy;MDT is short cure time and high accumulative survival rate,and Life-table method has a good prospect in assessing the effects of chemotherapy of leprosy.
分 类 号:R755[医药卫生—皮肤病学与性病学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222